Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00193713
Status:
COMPLETED
Last Update Posted:
2015-01-16
First Post:
2005-09-11
Brief Title:
Bifeprunox in the Treatment of Schizophrenia
Sponsor:
Solvay Pharmaceuticals
Organization:
Solvay Pharmaceuticals
Organization Data
Organization:
Solvay Pharmaceuticals
Class:
INDUSTRY
Study ID:
S1543004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Solvay Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None